Replies to post #3284 on Emergent Health Corp (EMGE)

[powerbattles]

Your critical feedback seems intentional, you're not offering tips on how to conduct due diligence on OTC companies. Let me clarify; no company declares that it will make every shareholder wealthy. Upon reviewing your historical posts, it appears you consist of expressions negative in virtually all the companies you discuss. Could you highlight a stock that meets your criteria or has no issues according to your standards?
In the realm of publicly traded companies, it's common to find aspects that one might not appreciate, sometimes even numerous elements. That's simply the nature of investments. There's no perfect company out there. Some of the concerns you raised below are already part of my investigation, I think that is not a big issue and I will address them this weekend in Part 2 and Part 3.

There is also a pending reverse split already enacted by the board and awaiting FINRA. The board met the deadline, and if FINRA has an issue with it, it's likely they're suspicious and you should be, too.

To address your statement quoted above FINRA does not approve reverse splits, but it does process reverse stock splits as part of its functions related to company corporate actions in the OTC market.
https://www.finra.org/investors/investing/investment-products/stocks/stock-splits

FINRA does play a role in reverse stock splits, but FINRA doesn't control or have the final authority over these decisions.
if the board of directors and shareholders approve r/s then FINRA doesn't have an issue with it because they don't control or have the final authority over these decisions. Companies seeking to execute a reverse stock split must follow certain regulatory procedures, including obtaining approval from their board of directors and, in most cases, obtaining shareholder approval.
Let me make it clear: in this case, they adhere to the rules and regulations. Therefore, please don't mislead or distort things. It's as clear as daylight that decisions are determined by the board of directors, not by FINRA.

Here's a tip on how to conduct due diligence: pay close attention to what you read and ensure you comprehend the information stated below.

In the best interests of the Corporation and its shareholders, the Corporation shall, at a time determined by the board of directors, but not later than Sep 30, 2023, effect a reverse split of the Corporation's outstanding shares of common stock...